Evidence map›Paper›PMID 40351647›Full record

ArticleJournal of orthopaedic case reports2025

Intramuscular Myxoma in the Vastus Medialis Muscle: A Case Report and Brief Review of the Literature.

Christos Siopis, Mikail Chatzivasiliadis, Byron Chalidis, Christos Koukos, S Samundeeswari, Stylianos Kapetanakis

Abstract readCase Reports
In one paragraph

Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christos SiopisDepartment of Orthopaedics, European Interbalkan Medical Center, Thessaloniki, Greece.
Mikail ChatzivasiliadisDepartment of Orthopaedics, European Interbalkan Medical Center, Thessaloniki, Greece.
Byron ChalidisDepartment of Orthopaedics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Christos KoukosSports Trauma and Pain Institute, Thessaloniki, Greece.
S SamundeeswariSri Lakshmi Narayana Institute of Medical Sciences, Puducherry, India.
Stylianos KapetanakisDepartment of Orthopaedics, European Interbalkan Medical Center, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Intramuscular myxomas (IMMs) are rare benign tumors of mesenchymal origin, typically occurring in middle-aged women. These tumors are characterized by hypocellular, hypovascular lesions rich in extracellular myxoid stroma. IMMs are most commonly found in the heart but rarely may affect large muscle groups such as the thighs, shoulders, and buttocks. While they are generally isolated lesions, IMMs may be associated with syndromes such as Mazabraud syndrome or McCune-Albright syndrome. Accurate diagnosis relies on imaging and histopathological evaluation, with surgical excision being the definitive treatment. Case Report: We present the case of a 25-year-old female patient who reported a noticeable dysmorphism in the inner thigh region without pain or functional impairment. Magnetic resonance imaging revealed a smooth-bordered, oval lesion in the vastus medialis muscle measuring 2.8 × 2 cm. A percutaneous biopsy confirmed the diagnosis of an IMM. Eventually, the intramuscular myxoma was surgically removed without complications. Conclusion: Accurate imaging and histopathological confirmation remain critical for diagnosis, and a case such as ours reinforces the need to consider IMMs in rare locations to optimize patient care.

Indexed as

benign tumorIntramuscular myxomamyxomathigh massvastus medialis

Identifiers

PMID40351647
PMCPMC12064253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.